You are here: Industry Insights > bag

News List

Fully-Automatical Non-PVC Film Soft Bag I.V Solution Production Line PharmaSources.com
December 28, 2017
Automatic PVC film bag I.V liquid production line introduced
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron Pharmaceutical-Technology
November 25, 2021
Norwegian vaccine and immunotherapy-focused biopharma Nykode Therapeutics started off in 2007 as Vaccibody, before rebranding this week to signal its significant growth and transformation plans.
Lilly, Boehringer's Jardiance bags FDA approval for heart failure firstwordpharma
August 19, 2021
The FDA has expanded the label for Eli Lilly and Boehringer Ingelheim's Jardiance (empagliflozin) to include reducing the risk of cardiovascular death plus hospitalisation for heart failure (HF) in adult patients with reduced ejection fraction (HFrEF).
Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval pharmatimes
July 22, 2021
Myovant Sciences and Gedeon Richter have gained an approval from the European Commission (EC) for its uterine fibroids treatment Ryeqo, the company announced 20th.
Sanofi’s Aubagio obtains EC approval for paediatric multiple sclerosis pharmaceutical-technology
June 22, 2021
Sanofi has obtained approval from the European Commission (EC) for its Aubagio (teriflunomide) to treat paediatric patients aged ten to 17 years with relapsing-remitting multiple sclerosis (RRMS).
Astellas’ Xtandi bags NICE approval in prostate cancer pharmatimes
June 10, 2021
Astellas’ oral treatment Xtandi has received approval from the National Institute for Health and Care Excellence (NICE) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).
Takeda’s dengue vaccine bags positive long-term efficacy results pharmatimes
May 26, 2021
Japanese pharma company Takeda has announced that its dengue vaccine candidate TAK-003 demonstrated continued protection through three years after vaccination, regardless of previous exposure to the disease.
Astellas’ Xtandi bags additional MHRA approval in prostate cancer pharmatimes
May 13, 2021
Japanese pharma company Astellas has announced that its prostate cancer therapy Xtandi has gained an approval for an additional indication from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Gland Pharma gets US FDA nod for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion expresspharma
April 25, 2021
Gland Pharma received approval from the United States Food and Drug Administration (US FDA) for generic Foscarnet Sodium Injection, 6000 mg/250 mL (24 mg/mL) Single-Dose Bag for Infusion.
TG Therapeutics’ ublituximab tops Sanofi’s Aubagio in MS trial pharmatimes
April 20, 2021
New York-headquartered biopharma company TG Therapeutics has revealed new data for its investigational therapy ublituximab, which demonstrated superiority over Sanofi’s Aubagio in patients with relapsing forms of multiple sclerosis (MS).